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Influence of plasma on the physical properties of ointments 
with quercetin
Effects of two independent variables – the content of quer-
cetin (0 or 1 or 1.5 or 5 %) and the content of plasma (0 or 2 
or 4 or 6 %) – on the organoleptic properties and rheological 
parameters of model formulations prepared on an amphi-
philic base were estimated. The consistency of all oint-
ments was uniform, and the content of quercetin and plas-
ma lay within the predefined range. Tested ointments are 
non-Newtonian systems. The content of quercetin and 
plasma was found to have a significant effect on the rheo-
logical properties of the ointments. An increase in the con-
tent of plasma in ointments was accompanied by a signifi-
cant increase in their hardness, viscosity and shear stress 
and a reduction of their spreadability. The best rheological 
properties were shown by formulation F-3, containing 1.5 % 
of quercetin and 2 % of plasma.
Keywords: quercetin, plasma, ointment, rheological prop-
erty
Plant raw materials are not used only as cosmetic preparations, but also in different 
prescription forms, including ointments. Flavonoids used in ointments are a valuable 
complement to antibiotic therapy, especially in the chronic and persistent course of certain 
infections (1).
One of such promising substances is quercetin. It is one of major bioflavonoids in hu-
man diet. Quercetin can be found in many vegetables, fruits as well as tea and grains (2). 
Many studies have demonstrated its biochemical and pharmacological properties (3). De-
pending on the concentration and location in the cell, it can exhibit both pro- and antioxidant 
properties. Antioxidant properties of quercetin are employed to scavenge ROS (reactive 
oxygen species) and find therapeutic application in the treatment of various diseases such 
as cancers as well as cardiovascular, ocular, autoimmune and infectious diseases (2, 3).
Studies in transgenic mice have demonstrated that quercetin and its derivatives re-
duce atopic dermatitis (4, 5). Phenolic extracts of Sapium sebiferum leaves exhibited inhibi-
tory effects on edema induced by dinitrofluorobenzene. Application of extracts also de-
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in mice (6). Quercetin derivatives can be used in prevention and treatment of diseases 
mediated by ultraviolet radiation such as photoaging and skin cancer.
Many studies have demonstrated antibacterial and antifungal activity of quercetin (7, 
8). Cushnie and Lamb (7) reported that flavonoids are capable of causing major structural 
and molecular changes in bacteria, including damage to the membranes, and inhibition of 
nucleic acid synthesis and cellular energy metabolism. Quercetin applied at a concentra-
tion of 16 mg/mL inhibited biofilm formation and virulence factors of Pseudomonas aerugi-
nosa. Mostafa and Ibrahem (8) administered quercetin in the form of a cream to patients 
with aphthous ulceration in the mouth and they showed that the time required to complete 
their cure was significantly shorter compared to patients treated with a solution of benzyd-
amine hydrochloride mouth wash.
Quercetin is a strongly hydrophobic substance and is most rapidly released from a hy-
drophilic base (9). Because of its low solubility in water, quercetin in blood plasma is bound 
to proteins, mainly albumin. The presence of hydroxy groups at C3 and C7 quercetin mole-
cules results in the formation of a complex of albumin, a protein which is the main compo-
nent of plasma (10). The compound of quercetin with albumin provides its transport system 
and determines their greater biological activity and efficacy (10, 11). The study conducted by 
Papadopoulou et al. (11) addressing the use of tryptophan fluorescence quenching revealed 
that of the four flavonoids examined (catechin, epicatechin, rutin, and quercetin), quercetin 
exhibited the strongest binding affinity at pH 7.4. Besides, the evidence suggested that bind-
ing of flavonoids to BSA did not change the molecular conformation of BSA.
Plasma is used in surgery, sports medicine and traumatology for the treatment of 
chronic wounds and in aesthetic medicine (12, 13). Autologous platelet-rich plasma (PRP) 
is a source of many growth factors that play a key role in the process of normal wound 
healing, such as platelet-derived growth factor (PDGF), transforming growth factor-b 
(TGF-b) and vascular endothelial growth factor (VEGF) (13). In addition, the leukocytes 
present in the preparation increase its antibacterial properties (12). Having been admini-
stered plasma, patients may take fewer standard drugs, which is particularly important in 
the case of concurrent diseases.
In the literature, there are no data on the use of plasma in ointment formulations with 
quercetin. The efficacy of an ointment formulation is affected by many factors, including 
the composition and nature of the substrate, as well as their rheological properties.
Therefore, the aim of this study was to determine the influence of the content of quer-
cetin (0 or 1 or 1.5 or 5 %) and plasma (0 or 2 or 4 or 6 %) on the organoleptic and rheologi-
cal parameters (hardness, viscosity, shear stress and spreadability) of model ointments 
prepared on the base of Lekobaza®. The latter was selected as the base because of its rheo-
logical and amphiphilic properties. This medium makes it possible to obtain an ointment 
with the consistency of a soft foam and good spreadability. Furthermore, this base is often 
used in practice due to its lack of interaction with the components introduced.
EXPERIMENTAL
Chemicals
Quercetin, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, was pur-
chased from Cayman Chemicals, Michigan, USA. Factor VIII free plasma, as spray dried 
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powder (protein content 89–94, water 2.5–7 and salt ≤ 2 %) was a gift from Biochefa Phar-
maceutical Research and Production Plant (Poland). Lekobaza® was purchased from 
Fagron (Pharma Cosmetic, Poland). Lekobaza® is an amphiphilic ointment comprising 
liquid paraffin 3.0 %, vaseline petrolatum jelly 32 %, glyceryl monostearate 3.0 %, cetostea-
ryl alcohol 9 %, propylene glycol 5 %, Tween-40 7 %, miglyol 912 2.0 %, aerosil 0.1 %, sorbic 
acid 0.2 % and water 38.7 %. All materials used in the study were p.a. and satisfy the re-
quirements of standards and certificates.
Preparation of ointment suspension
Based on the preliminary results, a suspension of 7 ointment formulation types was 
prepared, which differed in composition-concentration of quercetin (0, 1, 1.5, or 5 %) and 
plasma (0, 2, 4, or 6 %). Particles of quercetin were micronized using a pestle and mortar. 
Formulation F-6 contained only quercetin, 1 %, while F-7 only plasma, 4 %. All ointment 
formulations contained Lekobaza® as the base. Compositions of the different variants are 
shown in Table I. An appropriate amount of micronized quercetin (0 or 1 or 1.5 or 5 %) was 
mixed with the base in the 1:1 ratio (phase 1). Next, an adequate amount of plasma (0 or 2 
or 4 or 6 %) was mixed with the base in the 1:1 ratio (phase 2). Phase 1 concentrate was 
mixed with phase 2 concentrate in a Unguator® (UNGUATOR® 2100, Gako, Poland) and 
added to the rest of the base to obtain a final mass of 100.0 g of ointment. All preparations 
were additionally homogenized for 6 minutes in the Unguator® in order to obtain uniform 
consistency. Each of the variants was done in 5 replications.
Analysis of selected physicochemical properties of ointments
Particle size analysis. – An optical microscope (MT 4200 Series Meiji Techno Co. LTP, 
Japan) equipped with a camera, was used to study the particle size of quercetin. 100 par-
ticles of quercetin were measured applying total magnification of 400×. Microscopic fea-
tures of ointments were characterized by applying a small amount of the sample to a mi-
croscope slide, covering it with a cover slip, and observing under an E-600-Pol polarizing 
microscope (Nikon Corporation, Japan) at 1000× magnification. Images were captured 
with a digital camera (Olympus PD 26).
Spectrophotometric determination of quercetin and plasma. – To determine the content of 
quercetin, 10.0 mg of a relevant variant of ointment was weighed and dissolved in 10 mL 
of ethanol 96 %. For plasma, 10 mg of ointment was suspended in 10 mL of H2O, and sub-
sequently the supernatant was separated by centrifuging and the absorbance of the sam-
Table I. Composition (g) of preparations with quercetin
Ingredient
Formulation code
F-1 F-2 F-3 F-4 F-5 F-6 F-7
Quercetin 1.5 5.0 1.5 5.0 1.0 1.0 –
Plasma 6.0 2.0 2.0 6.0 4.0 – 4.0
Lekobaza® ad 100 100 100 100 100 100 100
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ples was measured. Absorbance (x) was measured in 1 cm quartz cuvettes using a CE 3021 
UV-Vis spectrometer (Cecil, UK). Concentration (y) was calculated on the basis of regres-
sion equations (quercetin y = 0.0744x + 0.0045 R2 > 0.999; plasma y = 0.0105x + 0.0221 R2 > 
0.999). Absorbance was measured at wavelengths (lmax) at which maximum absorbance 
was observed (lmax(quercetin) = 373.0 nm, lmax(plasma) = 280.0 nm). Photometric accuracy 
of the spectrophotometer was ± 0.005.
Determination of hardness. – Hardness tests were performed with the aid of a texture 
analyzer Shimadzu AUTOGRAPH, series EZ-LX/EZ-SX (Shimadzu Corporation, Analytical 
& Measuring Instruments Division, Japan) at 25 °C. A conical probe was immersed in the 
container containing the sample to a depth of 10 mm and moved at a speed of 2 mm s–1.
Viscosity measurements. – Ointment samples of 0.5 cm3 were subjected to shear stress 
in the space between the cone performing rotation and the fixed plate of a digital visco-
meter Brookfield CAP 2000+ (Brookfield Engineering Inc., USA) at 25 °C. The shear rate range 
from 66.66 to 1267 s–1 determined the size of shear stress and viscosity of the formulations.
Spreadability. – Spreadability of ointments was assayed using an extensometer. In-
creases of the surface areas (Π r2) of ointment formulations stretched between the exten-
someter plates were measured at one-minute intervals with increasing loads (14). The cor-
relation equation of the type y = ax + b describing the course of the above dependencies 
allows for the application of an integration method to calculate the areas under extensibil-








where Stest is the surface area of the formulations tested, and Scon is the surface area of the 
control formulation without active drug (Formulation F-7) expressed in mm2.
Statistical analysis
The results were calculated as mean values ± SD of five replicates. Statistical analysis 
was carried out using the Statistica (StatSoft Inc.) software. The effect of two independent 
variables was determined: the concentration of quercetin and plasma concentration on 
density, viscosity, spreadability and shear stress of ointment formulations. Correlations 
between the parameters were analyses by the Pearson correlation coefficient (r). Statistical 
significance of the differences between the means was analyzed using the Fisher-Snedecor 
test. The level of p ≤ 0.05 was adopted to indicate statistical significance.
RESULTS AND DISCUSSION
Analysis of microscopic images showed that natural quercetin had a crystalline struc-
ture with a particle size of 10.70 ± 4.84 mm. The crystals observed under the microscope 
were straight, elongated, with blunt ends and no local deformations. Crystals were not 
found to form aggregates (Fig. 1a). After micronization, the average size of quercetin was 
5.62 ± 2.46 mm (Fig. 1b), and 4.42 ± 1.87 mm in prepared formulations.
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As shown in Figs. 2a-c, quercetin solids in the ointments were fragmented and dis-
persed by mixing.
The ointment was uniform in all variants. Results revealed that the drug substance 
was generally evenly and uniformly dispersed. Contents of quercetin and plasma were 
within the predefined range in all formulations. Drug content was evaluated by calculat-
ing the mean recovery (%) from three samplings while homogeneity was evaluated by 
determining the relative standard deviation (% RSD). Mean recoveries (from 99.6 to 110 %) 
and RSD values (< 4 %) are in agreement with Polish Pharmacopeia (15).
Hardness of the ointment base was observed to increase with increasing the content 
of solid matter in it: the lowest hardness was achieved for formulation F-6, and the highest 
for F-4 (Table II).
Spreadability is the measure of increase in ointment surface under pressure. Highly 
spreadable ointments cover the surface of a lesion easily, which improves the diffusion of 
Fig. 1. Optical microscope images of quercetin (magnification 400×): a) before micronization, and b) 
after micronization.
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Fig. 2. Polarized microscope images of quercetin ointments (magnification 1000×): a) F-3, b) F-6 and c) F-7.
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drug substance from a dosage form to the external compartment. Ointment spreadability 
decreases with increasing the content of plasma (Table III). Ointments containing 2 % 
plasma are more spreadable compared to formulations with 6 % plasma. The results indi-
cate that increasing the plasma content in ointments worsens their rheological properties, 
suggesting the need to reduce its content. The largest area under the extensibility curve is 
characterized by formulation F-6 (containing only quercetin) (1734.07 mm2) and it is about 
22.87 % higher compared to formulation F-7 (containing only plasma). With regard to 
spreadability, the resultant ointments could be grouped in ascending order: F-6 < F-3 < F-2 
< F-7 < F-5 < F-4 < F-1 (where F-1 has the lowest and F-6 the highest value).
The course of flow curves of all prepared ointments indicates a non-Newtonian char-
acter. The relationship between shear stress and shear rate is not a straight line running 
through the origin of the coordinate system within the range of shear rates from 66.66 to 
1267 s–1. The highest shear stress values were obtained for F-1 and the lowest for F-6 (Table 
II). In the shear rate range from 66.66 to 733 s–1, a sharp decline in shear stress is observed 














F-1 2592 ± 187 1178 ± 124 3533 ± 244 460 ± 22 627 ± 17
F-2 1521 ± 174 415 ± 11 1245 ± 45 318 ± 7 433 ± 21
F-3 993 ± 80 431 ± 12 1294 ± 24 139 ± 8 189 ± 11
F-4 2978 ± 138 1050 ± 94 1350 ± 60 404 ± 11 551 ± 34
F-5 1622 ± 117 643 ± 35 3150 ± 149 386 ± 9 527 ± 13
F-6 981 ± 91 370 ± 22 1110 ± 98 75 ± 6 102 ± 5
F-7 1316 ± 170 585 ± 12 1755 ± 73 240 ± 16 327 ± 16
Table III. Correlation equations (y = a + bx) that describe ointment spreadability 
Formulation 
code a ± da b ± db R
2 Surface area 
(mm2) i(P)
F-1 198.39 ± 9.78 1.9665 ± 0.097 0.9691 803.84 0.57
F-2 270.76 ± 15.24 2.9071 ± 0.164 0.9621 1589.63 1.13
F-3 254.64 ± 11.20 2.6032 ± 0.114 0.977 1607.34 1.14
F-4 157.81 ± 8.32 1.4279 ± 0.075 0.9716 1123.62 0.80
F-5 214.03 ± 15.27 2.3204 ± 0.166 0.9788 1319.59 0.94
F-6 324.48 ± 22.15 3.1664 ± 0.216 0.943 1734.07 1.23
F-7 246.14 ± 14.52 2.3029 ± 0.136 0.9566 1411.24 1.00
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whereas at higher shear rates from 733 to 1267 s–1 shear stress is maintained at a similar 
level for each ointment formulation.
Spreadability is a function of structural viscosity: the lower the viscosity, the higher 
is the spreadability. Fig. 3 shows the impact of ointment composition on the viscosity (h) in 
dependence on the share rate.
As shown in Fig. 3, an increase in plasma and quercetin content in ointments signifi-
cantly (p < 0.05) increases the viscosity at low shear rates. However, when the shear rate 
increased, the difference in viscosity of the investigated formulations was not significant. 
In all cases, viscosity decreased gradually with increasing the shear rate.
Results of the analysis of the correlation between the composition of ointments and 
their physical parameters (hardness, spreadability, viscosity, shear stress) are summarized 
Fig. 3. Effect of formulation composition on its viscosity in dependence on the shear rate.
Table IV. Pearson coefficients between the composition of quercetin ointments and the examined parameters
Ingredient
Hardness Spreadability Viscosity Shear stress
r p r p r p r p
Quercetin 
concentration 0.321 ≤ 0.05 –0.283 ≤ 0.05 0.357 ≤ 0.05 0.249 ≤ 0.05
Plasma 
concentration 0.941 ≤ 0.001 –0.983 ≤ 0.001 0.775 ≤ 0.001 0.899 ≤ 0.001
r – Pearson correlation coefficient; p – significance
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in Table IV. It can be seen that plasma concentration in the ointment base was a factor that 
had a significant positive correlation with hardness (r = 0.941, p ≤ 0.001), viscosity (r = 0.775, 
p ≤ 0.001) and flow (r = 0.899, p ≤ 0.001).
It was found that there was a weak positive correlation (for viscosity: r = 0.357, p ≤ 0.05; 
for flow: r = 0.249, p ≤ 0.05; for hardness: r = 0.321, p ≤ 0.05) between the content of quercetin 
in the base ointment and rheological parameters such as viscosity and shear stress.
An inverse correlation was found between spreadability and quercetin content (r = 
–0.283, p ≤ 0.05) as well as the content of plasma (r = –0.983, p ≤ = 0.001).
Results of the comparison of the hardness, spreadability and viscosity of the oint-
ments prepared in this study indicated that individual preparations had different physi-
cochemical properties. Differences in spreadability and viscosity of the ointments resulted 
in different amounts applied to patients in clinical settings and different feel on the skin; 
these variations may affect the therapeutic effectiveness of the preparation (16). In the 
evaluation of rheological parameters, the best properties were those of formulation F-6, 
which does not contain plasma, and formulations F-2 and F-3 containing 2 % plasma and 
5 and 1.5 % quercetin, respectively.
These data are difficult to discuss because there is no scientific literature addressing 
this issue. There are no ready-made formulations available on the pharmaceutical market 
that would contain both quercetin and plasma. Few works involve in vitro and in vivo stud-
ies of semi-solid formulations with quercetin (4, 9). Polyphenolic extracts constitute an 
attractive ingredient for cosmetics and pharmacy (16).
Among the prepared ointments, formulation F-3 (containing 1.5 % quercetin and 2 % 
plasma) showed the best rheological properties. The following stage should involve evalu-
ation of interactions between the medicinal substance and other ointment ingredients. An 
effective form of therapy still requires more precise specification of the optimum concen-
tration and determination of the stability of active substances.
CONCLUSIONS
The experiment indicates that quercetin has a significant effect on the rheological 
parameters of ointment formulations within the tested content range. Their hardness, vis-
cosity and shear stress increase and their spreadability decreases with increasing the con-
tent of plasma in ointments. There is a weak positive correlation between the content of 
quercetin in ointment base and the rheological parameters such as hardness, viscosity and 
shear stress.
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